Serum somatomedin stimulation in thyroxine-treated hypophysectomized rats

Area of Science:

• Endocrinology
• Growth Factor Research
• Thyroid Hormone Action

Background:

• Somatomedins are crucial growth factors regulated by the pituitary gland.
• Hypophysectomy in rats leads to diminished somatomedin activity and impaired growth.
• Thyroid hormones (T4 and T3) play a role in metabolic regulation and growth.

Purpose of the Study:

• To investigate the role of L-thyroxine (T4) in regulating somatomedin activity in hypophysectomized rats.
• To determine if T4 can restore somatomedin activity independently or in conjunction with bovine growth hormone (bGH).
• To explore the direct effects of T4 and T3 on somatomedin-mediated sulfation in vitro.

Main Methods:

• Somatomedin activity measured via sulfate incorporation into embryonic chick cartilage.
• Hypophysectomized male rats treated with L-thyroxine (T4) and/or bovine growth hormone (bGH).
• In vitro experiments adding T4 or T3 to normal rat serum and serum-free medium.

Main Results:

• T4 treatment, alone or with bGH, restored serum somatomedin activity to normal levels in hypophysectomized rats.
• Serum from bGH-treated hypophysectomized rats showed significantly lower somatomedin activity compared to normal.
• Higher concentrations of T4 and T3 enhanced sulfation potency in normal serum, but had minimal effect in serum-free medium.

Conclusions:

• L-thyroxine (T4) can restore somatomedin activity in the absence of adequate growth hormone (GH).
• T4 may directly stimulate somatomedin production or be metabolized into an active sulfation factor.
• Thyroid hormones exhibit a dose-dependent effect on somatomedin activity and sulfation processes.